Please wait a minute...
Journal of ZheJiang University(Medical Science)  2015, Vol. 44 Issue (2): 174-178    DOI: 10.3785/j.issn.1008-9292.2015.03.009
Apoptosis of acute myeloid leukemia HL-60 cells induced by CDK inhibitor SNS-032 and its molecular mechanisms
HAN Yan-xia1,2, YOU Liang-shun1, LIU Hui1, MAO Li-ping1, YE Xiu-jin1, QIAN Wen-bin1
1. Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
2. Department of Hematology, Jiaxing Second People's Hospital, Jiaxing 314000, China
Download: HTML (   PDF(740KB)
Export: BibTeX | EndNote (RIS)      


Objective: To investigate the effects of cycle-dependent kinase (CDK) inhibitor SNS-032 on apoptosis in human acute myeloid leukemia (AML) HL-60 cells and its molecular mechanisms. Methods: Cultured AML HL-60 cells were treated with various concentrations of SNS-032. Cell apoptosis was determined with flow cytometry;cell viability was measured by MTT assay; the profiles of microRNA expression of HL-60 cells were analyzed by microRNA microarray;the protein expressions of JAK2/STAT3 pathway were detected by Western blotting. Results: Apoptosis of AML HL-60 cells was induced by SNS-032; the rate of apoptosis was (5.9±1.7)%, (12.1±3.1)% and (59.4±3.6)% when HL-60 cells were treated with 0,100 and 200 nmol/L SNS-032. MicroRNA microarray analysis revealed that the levels of miR-30a, miR-183, miR-20b, miR-26b, miR-20a, miR-589, miR-107, miR-181a, miR-106a, miR-17 and miR-378c were down-regulated by SNS-032,whereas the levels of miR-320a and miR-H7* were up-regulated. Western blotting showed that SNS-032 strongly inhibited phosphorylation of STAT3 and protein expression of JAK2,C-MYC and MCL-1. Conclusion: CDK inhibitor SNS-032 can induce apoptosis of AML HL-60 cells, which is associated with the inhibition of MCL-1,C-MYC and JAK2/STAT3, and down-regulation of miR-17-92 family.

Key wordsLeukemia, myeloid, acute      MicroRNAs      Cyclin-dependent kinases/ biosynthesis      Janus kinases      STAT3 transcription factor      Protein-tyrosine kinases/metabolism      Signal transduction      HL-60 cells      Apoptosis      Tumor cells, cultured     
Received: 05 September 2014      Published: 25 March 2015
CLC:  R552  
Cite this article:

HAN Yan-xia, YOU Liang-shun, LIU Hui, MAO Li-ping, YE Xiu-jin, QIAN Wen-bin. Apoptosis of acute myeloid leukemia HL-60 cells induced by CDK inhibitor SNS-032 and its molecular mechanisms. Journal of ZheJiang University(Medical Science), 2015, 44(2): 174-178.

URL:     OR


目的:探讨细胞周期蛋白依赖激酶(CDK)抑制剂SNS-032诱导人急性髓系白血病HL-60细胞凋亡的效应及可能的机制。 方法:以CDK抑制剂SNS-032作用于HL-60细胞株,实验细胞分为对照组、SNS-032组、白细胞介素(IL)-6组和SNS-032+IL-6组。MTT法检测细胞存活率,流式细胞术检测细胞凋亡, microRNA芯片技术分析细胞microRNA的表达谱差异,蛋白质印迹法检测JAK/STAT3相关信号通路蛋白的表达。 结果:SNS-032可降低细胞存活率,诱导HL-60细胞凋亡,对照组、100nmol/L和200nmol/L的SNS-032干预组细胞凋亡率分别为(5.9±1.7)%、(12.1±3.1)%和(59.4±3.6)%。microRNA芯片分析结果显示,SNS-032显著下调HL-60细胞miR-30a、miR-183、miR-20b、miR-26b、miR-20a、miR-589、miR-107、miR-181a、miR-106a、miR-17和miR-378c的表达水平,显著上调miR-320a的表达水平。蛋白质印迹法显示SNS-032可抑制STAT3的磷酸化和JAK2、MCL-1、C-MYC蛋白的表达。作为JAK/STAT3通路的激活剂,IL-6联合SNS-032不能逆转后者对HL-60细胞的杀伤作用(P>0.05),也不能逆转SNS-032对JAK2蛋白表达和磷酸化STAT3的抑制作用。结论:SNS-032能显著诱导人急性髓系白血病 HL-60细胞发生凋亡,其机制可能与抑制JAK2和STAT3磷酸化、抑制MCL-1和C-MYC及与之相关的miR-17-92基因簇表达水平有关。

关键词: 白血病,髓样,急性,  微RNAs,  细胞周期蛋白质依赖激酶类/生物合成,  Janus激酶类,  STAT3转录因子,  蛋白酪氨酸激酶类/代谢,  信号传导,  HL-60细胞,  细胞凋亡,  肿瘤细胞,培养的 

[1] ASGHAR U, WITKIEWICZ A K, TURNER N C, et al. The history and future of targeting cyclin-dependent kinases in cancer therapy [J]. Nat Rev Drug Discov, 2015, 14(2):130-146.
[2] KUMAR S K, LAPLANT B, CHNG W J, et al. Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma [J]. Blood, 2015, 125(3):443-448.
[3] DICKSON M A. Molecular pathways:CDK4 inhibitors for cancer therapy [J]. Clin Cancer Res, 2014, 20(13):3379-3383.
[4] CHEN R, WIERDA W G, CHUBB S, et al. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia [J]. Blood, 2009, 113(19):4637-4645.
[5] WALSBY E, LAZENBY M, PEPPER C, et al. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine [J]. Leukemia, 2011, 25(3):411-419.
[6] LEE Y, AHN C, HAN J, et al. The nuclear RNase III Drosha initiates microRNA processing [J]. Nature, 2003, 425(6956):415-419.
[7] DENLI A M, TOPS B B, PLASTERK R H, et al. Processing of primary microRNAs by the Microprocessor complex [J]. Nature, 2004, 432(7014):231-235.
[8] LI Z, LU J, SUN M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations [J]. Proc Natl Acad Sci USA, 2008, 105(40):15535-15540.
[9] DIXON-MCIVER A, EAST P, MEIN C A, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia [J]. PLoS One, 2008, 3(5):e2141.
[10] JIN H Y, LAI M, XIAO C. microRNA-17~92 is a powerful cancer driver and a therapeutic target [J]. Cell Cycle, 2014, 13(4):495-496.
[11] XIANG J, WU J. Feud or friend? The role of the miR-17-92 cluster in tumorigenesis [J]. Curr Genomics, 2010, 11(2):129-135.
[12] CHANG Q, BOURNAZOU E, SANSONE P, et al. The IL-6/JAK/STAT3 feed-forward loop drives tumorigenesis and metastasis [J]. Neoplasia, 2013, 15(7):848-862.

[1] LIANG Gang,NIU Yumiao,LI Yihan,Wei Anyi,DONG Jingyin,ZENG Linghui. Rapamycin treatment starting at 24 h after cerebral ischemia/reperfusion exhibits protective effect on brain injury in rats[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 443-449.
[2] LIN Ying,YAO Yingjia,LIANG Xicai,SHI Yue,KONG Liang,XIAO Honghe,WU Yutong,NI Yingnan,YANG Jingxian. Osthole suppresses amyloid precursor protein expression by up-regulating miRNA-101a-3p in Alzheimer's disease cell model[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 473-479.
[3] LIN Kana,LIN Meili,GU Yingfen,ZHANG Shunguo,HUANG Shiying. G protein-coupled receptor 17 is involved in CoCl2-induced hypoxic injury in RGC-5 cells[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 487-492.
[4] ZHU Feng,FAN Miao,XU Ziwei,CAI Yiting,CHEN Yizhen,YU Shuang,ZENG Linghui. Neuroprotective effect of rapamycin against Parkinson's disease in mice[J]. Journal of ZheJiang University(Medical Science), 2018, 47(5): 465-472.
[5] LIN Meina,XU Ruiyuan,ZHANG Tao,ZHANG Lin,MEI Xuqiao. Expression of c-FLIP in peripheral blood mononuclear cells of patients with rheumatoid arthritis and its relation with extrinsic apoptotic pathway[J]. Journal of ZheJiang University(Medical Science), 2018, 47(4): 381-388.
[6] QIAN Bo,ZHANG Yanling,MO Xuming. Research progress on transcription factors and signal pathways involved in congenital esophageal atresia[J]. Journal of ZheJiang University(Medical Science), 2018, 47(3): 239-243.
[7] TIAN Guangfeng,GAO Hui,HU Shasha,SHU Qiang. Research progress on genetic and epigenetic mechanisms in congenital heart disease[J]. Journal of ZheJiang University(Medical Science), 2018, 47(3): 227-238.
[8] LI Fushan,FANG Ran,RAO Lin,MENG Feilong,ZHAO Xiaoli. Research progress on exosomes in diagnosis and treatment of cardiovascular diseases[J]. Journal of ZheJiang University(Medical Science), 2018, 47(3): 320-326.
[9] PAN Zongfu,FANG Qilu,ZHANG Yiwen,LI Li,HUANG Ping. Identification of key pathways and drug repurposing for anaplastic thyroid carcinoma by integrated bioinformatics analysis[J]. Journal of ZheJiang University(Medical Science), 2018, 47(2): 187-193.
[10] LIU Tingting,WANG Lingxiao,YANG Xiaohui,YAO Zhiqing,CAI Huizhen. TLR/NF-κB independent signaling pathway in TNF-α suppression of diabetic MyD88-knockout mice after Lycium barbarum polysaccharides administration[J]. Journal of ZheJiang University(Medical Science), 2018, 47(1): 35-40.
[11] DING Jingjing,LU Yunbi. Research progress on receptor interacting proteins in inflammation[J]. Journal of ZheJiang University(Medical Science), 2018, 47(1): 89-96.
[12] WEI Zhenlong,SHI Wengui,CHEN Keming,ZHOU Jian,WANG Minggang. Icaritin promotes maturation and mineralization of mouse osteoblast MC3T3-E1 cells through CXCR4/SDF-1 signal pathway[J]. Journal of ZheJiang University(Medical Science), 2017, 46(6): 571-577.
[13] ZHANG Yi,ZHANG Li,ZHANG Qiyu,HONG Weilong,LIN Xiaohua. microRNA-222 regulates proliferation and apoptosis of fibroblasts in hypertrophic scar via matrix metalloproteinase 1[J]. Journal of ZheJiang University(Medical Science), 2017, 46(6): 609-617.
[14] JIANG Yiqian, GUO Qingmin, GU Jianzhong, XU Xiaoping, AN Suhong, SU Fang, BAO Yanhong, HUANG Changxin, GUAN Xiaoxiang. Effect of microRNA-29b on proliferation and migration of breast cancer cells and its molecular mechanism[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 349-356.
[15] TIAN Hua, CHEN Yang, ZHAO Jiangang, LIU Daren, LIANG Gang, GONG Weihua, CHEN Li, WU Yulian. Effects of siRNAs targeting CD97 immune epitopes on biological behavior in breast cancer cell line MDA-MB231[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 341-348.